For citations:
Bashlyk VO, Kudaibergenova AG, Artemyeva AS, Muravtseva AL, Chirsky VS, Semiglazova TY, Klimenko VV, Semiglazov VF. Breast cancer biomarker (ER, PR, HER2) changes in the phenotype after neoadjuvant treatment. Meditsinskiy sovet = Medical Council. 2018;(10):146-149. (In Russ.) https://doi.org/10.21518/2079-701X-2018-10-146-149